Clinical trial Recruiting at 1 site Interventional Ages Any age to 48 Hours

Surfactant given through a laryngeal mask for preterm babies with RDS in Vietnam

Official title: Surfactant Therapy Via Supraglottic Airway Device Versus Endotracheal Intubation to Prevent Mechanical Ventilation in Preterm Neonates With Respiratory Distress Syndrome: An Open-label, Non-inferiority, Randomized Controlled Trial at a Level-III Neonatal Intensive Care Unit in Vietnam

Run by Karolinska Institutet · NCT07098910 · Data updated 2026-11-12

For preterm babies under 34 weeks with respiratory distress, the team will try giving surfactant through a soft throat mask (SALSA) instead of an endotracheal tube (INSURE) to see if it reduces the need for invasive breathing support.

More Respiratory Distress Syndrome in Premature Infant trials

Quick facts

Study typeInterventional
AgesAny age to 48 Hours
SexAll
Enrollment440 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations1 site (Hanoi)
StatusRecruiting
StartedSeptember 28, 2025
Main results expectedDecember 31, 2028
Study endsMarch 30, 2029
Registry record updatedMay 27, 2026
Trial IDNCT07098910 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Inborn preterm infants born before 34 weeks, weighing ≥750 g, under 48 hours old with RDS on CPAP/NIPPV and requiring FiO2 >0.30 to maintain target oxygenation are the intended participants.

Probably not a fit

Infants already intubated or mechanically ventilated, those with prior surfactant, known pneumothorax, major malformations, or who need immediate invasive support are unlikely to benefit from SALSA in this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial will compare surfactant delivery via a supraglottic/laryngeal mask airway (SALSA) to the standard INSURE technique (intubation, surfactant, extubation) in preterm infants with respiratory distress syndrome. Eligible inborn neonates are under 34+0 weeks gestation, weigh at least 750 g, are less than 48 hours old, and require surfactant while on non-invasive support with FiO2 >0.30. The primary outcome is avoidance of invasive mechanical ventilation within three days of treatment, with safety and feasibility outcomes also recorded. The trial is being conducted at Phu San Hanoi Hospital with international academic collaborators and uses preterm-sized supraglottic devices introduced after a prior feasibility study.

Why it matters

Potential benefit: If successful, SALSA could reduce the need for endotracheal intubation and its complications, making surfactant delivery safer and simpler for very preterm infants, especially in resource-limited settings.

How similar studies have gone: Smaller studies and a recent feasibility study using preterm-sized supraglottic devices have shown promising results for SALSA, but large randomized data in very preterm populations remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Inborn neonate (=born in the hospital), AND
* Gestational age \<34+0 weeks, AND
* Birth weight ≥750g, AND
* Age \<48 hours, AND
* Diagnosis of RDS, confirmed with a chest x-ray or lung ultrasound, except in cases where immediate treatment is necessary and imaging would cause a delay AND
* Indication for surfactant treatment: Infant on non-invasive support (CPAP/NIPPV) and FiO2 \>0.30 to maintain oxygen saturation (SpO2) between 90% and 95%

Exclusion Criteria:

* Severe respiratory insufficiency in need of intubation at delivery room
* Severe respiratory insufficiency in need of intubation and invasive mechanical ventilation after arrival to NICU
* Previous surfactant administration
* Previous invasive mechanical ventilation
* Known pneumothorax
* Major malformations
* Physician not confident with study intervention
* The physician decided not to include the patient due to a preference for performing INSURE
* Excluded due to time constraints preventing completion of informed consent and trial procedures

Where it's running

  • Phu San Hanoi Hospital - Hanoi Obstetrics and Gynecology Hospital
    Hanoi, Vietnam
    Recruiting

Study contacts

  • Principal investigator: Tobias Alfvén, Professor, M.D, Ph.D — Department of Global Public Health, Karolinska Institutet, Solna, Sweden
  • Study coordinator: Tobias Alfvén, Professor, M.D, Ph.D
  • Email: tobias.alfven@ki.se
  • Phone: +46 70 757 80 93

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.